+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sleep-Wake Disorder Market 2019-2025

  • PDF Icon


  • May 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4803293
UP TO OFF until Dec 31st 2022
Global Sleep-Wake Disorder Market Size, Share & Trends Analysis Report by Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Disorders, and Others) and by Treatment (Therapies, Medications, and Devices) and Forecast, 2019 - 2025.

Sleep-wake disorders are the common disorders that are associated with the sleep quality and quantity of an individual. Lack of sleep negatively affects the health of a person, including the level of concentration of a person. It certainly leads to depression, insomnia, and restlessness in life. There are several new therapies in the product pipeline of major companies that provide complete sleep solutions to sleep-wake disorders to patients. Increasing prevalence of lifestyle-oriented diseases such as snoring, sleep-waking, and depression, demands the diagnosis, therapies, and treatment for such disorders; thereby act as one of the major factors for the growth of the market. According to the National Institute of Mental Health, in 2015, around 16.1 million people, aged 18 years or above, suffered from depression in the US. Moreover, the ongoing research activities on ill-effects of sleep deficiency and the growing adoption of sleep-wake devices in hospitals and sleep clinics are further marking a growth opportunity for the global sleep-wake disorder market.

The global sleep-wake disorder market is further analyzed on the basis of geographical regions, including North America, Europe, Asia-Pacific, and Rest of the World. North America contributed a prominent share in the global sleep-wake disorder market in 2018. This is attributed to well-developed healthcare infrastructure and rising awareness of therapies and devices associated with the sleep-wake disorder. Asia-Pacific is projected to witness the fastest growth rate, in terms of revenue, in the global sleep-wake disorder market during the forecast period. Increasing sleep-wake patient population across Asian countries such as China, India, and Japan, is significantly propelling the market growth in Asia-Pacific.

Some of the players operating in the global sleep-wake disorder market include Jazz Pharmaceuticals, Inc., Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, Inc., RespireRx Pharmaceuticals Inc., Medtronic PLC Teva Pharmaceutical Industries Ltd., and Vanda Pharmaceuticals Inc. The companies are focused on the development of innovative products for sleep-wake disorder market to stay competitive in the global market. Geographical expansion, merger and acquisition, partnership, collaboration, finding a new market or innovate in their core competency in order to expand individual market share are some of the key strategies adopted by major market players.

Research Methodology

The market study of the global sleep-wake disorder market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog
The report is intended for healthcare providers, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. Global Sleep-Wake Disorder Market Research and Analysis by Type
2. Global Sleep-Wake Disorder Market Research and Analysis by Treatment

The Report Covers
  • Comprehensive research methodology of the global sleep-wake disorder market.
  • This report includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global sleep-wake disorder market.
  • Insights about market determinants which are stimulating the global sleep-wake disorder market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Koninklijke Philips N.V. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Merck KGaA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Neurocrine Biosciences, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. RespireRx Pharmaceuticals Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Medtronic PLC Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Sleep-Wake Disorder Market by Type
5.1.1. Insomnia
5.1.2. Hypersomnia
5.1.3. Sleep Apnea
5.1.4. Circadian Rhythm Disorders
5.1.5. Others
5.2. Global Sleep-Wake Disorder Market by Treatment
5.2.1. Therapies
5.2.2. Medications
5.2.3. Devices
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Aeroflow, Inc.
7.2. Airing, Inc.
7.3. Arena Pharmaceuticals, Inc.
7.4. BMC Medical Co., Ltd.
7.5. Cephalon, Inc.
7.6. Fisher & Paykel Healthcare Corp. Ltd.
7.7. Jazz Pharmaceuticals Inc.
7.8. Koninklijke Philips N.V.
7.9. Medtronic PLC
7.10. Merck KGaA
7.11. Natus Medical Inc.
7.12. Neurocrine Biosciences, Inc.
7.13. Pfizer Inc.
7.14. ResMed Inc.
7.15. RespireRx Pharmaceuticals Inc.
7.16. Sanofi SA
7.17. SleepNet Corp.
7.18. Somnarus, Inc.
7.19. Somnetics International, Inc.
7.20. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aeroflow, Inc.
  • Airing, Inc.
  • Arena Pharmaceuticals, Inc.
  • BMC Medical Co., Ltd.
  • Cephalon, Inc.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Jazz Pharmaceuticals Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merck KGaA
  • Natus Medical Inc.
  • Neurocrine Biosciences, Inc.
  • Pfizer Inc.
  • ResMed Inc.
  • RespireRx Pharmaceuticals Inc.
  • Sanofi SA
  • SleepNet Corp.
  • Somnarus, Inc.
  • Somnetics International, Inc.
  • Teva Pharmaceutical Industries Ltd.